Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000561599 | SCV000675616 | likely benign | Hereditary cancer-predisposing syndrome | 2023-05-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000609138 | SCV000727176 | likely benign | not specified | 2018-02-02 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000798867 | SCV000938505 | benign | Tuberous sclerosis 2 | 2024-12-26 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000798867 | SCV002040282 | likely benign | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV003736826 | SCV004562729 | uncertain significance | not provided | 2023-10-10 | criteria provided, single submitter | clinical testing | The TSC2 c.5311C>G; p.Pro1771Ala variant (rs777006583), to our knowledge, is not reported in the medical literature but is reported in ClinVar (Variation ID: 486616). This variant is found in the general population with an overall allele frequency of 0.0016% (4/250168 alleles) in the Genome Aggregation Database. Computational analyses are uncertain whether this variant is neutral or deleterious (REVEL: 0.526). Due to limited information, the clinical significance of this variant is uncertain at this time. |